Formulation and Characterization of Hyaluronic Acid Anchored Polycaprolactone Nanoparticles for Delivery of Anticancer Drugs
Abstract
Methotrexate (MTX), a stoichiometric inhibitor of dihydrofolate reductase, is a chemotherapeutic agent for treating a variety of neoplasms. The objective of the present study was to synthesize nanoparticles of MTX using hyaluronic acid-polyethyleneglycol-polycaprolactone (HA-PEG-PCL) copolymer for tumor targeting. Targeting efficiency of HA-PEG-PCL nanoparticles was compared with non-HA-containing nanoparticles polycaprolactone. The copolymers were chemically synthesized and characterized by IR and Nuclear Magnetic Resonance (NMR) spectroscopes. The nanoparticles were characterized for shape and morphology by transmission electron microscopy (TEM), particle size, percentage of drug entrapment and in-vitro drug release profile. Differential scanning calorimetry (DSC) and X-ray diffraction (XRD) studies were also performed to appraise the crystalline or amorphous nature of MTX inside the polymer matrix. Formulations were prepared using different MTX: polymer ratios (1:0.05-3:0.15 w/w) and the optimum formulation with the drug: polymer ratio of 1:0.05 showed the mean particle size of 185 ± 2.21 nm and entrapment efficiency of 93.16 ± 2.1% in the case of HA-PEG-PCL nanoparticles, while the values were 140 ± 1.24 nm and 90.12 ± 1.3%, respectively, in the case of PCL nanoparticles. The nanoparticles prepared using copolymers HA-PEG-PCL showed their potential to sustain the MTX release. MTX-HA-PEG-PCL nanoparticles showed 95.08 ± 2.50% release of MTX in 96 hours while MTX-PCL nanoparticles released almost 100% of the drug in the same duration. The stability was evaluated in terms of particle size and residual drug content, the nanoparticles formulations were found to be more stable at 5 ± 3°C and then 40 ± 2°C. These results suggest that HA-PEG-PCL nanoparticles could be an efficient delivery system for MTX for targeted therapy of cancer.
Keywords:
Methotrexate, Hyaluronic acid, Polycaprolactone, Nanoparticles, CancerDOI
https://doi.org/10.25004/IJPSDR.2022.140612References
Agarwal A, Asthana A, Gupta U, Jain NK. Tumour and dendrimers: a review on drug delivery aspects. J Pharm Pharmacol. 2008; 60(6):671-688.
Agarwal A, Saraf S, Asthana A, Gupta U, Gajbhiye V, Jain NK. Ligand based dendritic sytems for tumor targeting. Int J Pharm. 2008; 350:3-13.
Allemann E, Gurny R, Doelker E. Drug–loaded nanoparticles preparation method and drug targeting tissues. Eur J Pharm Biopharm. 1993; 39:173-191.
Cavallaro G, Mariano L, Salmaso S, Caliceti P, Gaetano G. Folate mediated targeting of polymeric conjugates of gemcitabine. Int J Pharm. 2006; 307:258-269.
Moffat AC, Osselton MD, Widdop B. Clarke’s analysis of drugs and poisons. Pharmaceutical Press, London. 2011.
Zhang Y, Jin T, Zhuo RX. Methotrexate-loaded biodegradable polymeric micelles: Preparation, physicochemical properties and in vitro drug release. Colloids Surf B Biointerfaces 2005; 44: 104-109.
Goldman ID, Mat herly LH. T he cellular pharmacolog y of methotrexate. Pharmacol Ther 1985; 28: 77-102.
Khan ZA, Tripathi R, Mishra B. Methotrexate: A detailed review on drug delivery and clinical aspects. Expert Opin Drug Deliv. 2012; 9: 151-169.
Fransson LA. Mammalian polysaccharides. In: Aspinall O, editor. The polysaccharides. Vol. 3. New York: Academic Press.1985; p 347-348.
Laurent TC. Structure of hyaluronic acid. In: Balazs EA, editor. Chemistry and molecular biology of the intercellular matrix. New York: Academic Press. 1970; p 703-721.
Scott JE, Cummings C, Brass AY, Chen Y. Secondary and tertiary structures of hyaluronan in aqueous solution, investigated by rotary shadowing-electron microscopy and computer stimulation. Biochem J. 1991; 274:699-705.
Wang C, Thor AD, Moore DH, Zhao Y, Kerschmann R, Stern R, Watson PH, Turley EA.The over expression of RHAMM, a hyaluronan-binding protein that regulates ras signalling, correlates with over-expression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clin Cancer Res. 1998; 4:567-576.
Hall CL, Yang BH, Yang XW, Zhang SW, Turley M, Samuel S, Lange LA, Wang C, Curpen GD, Savani RC, Greenberg AH, Turley EA. Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for h-ras transformation. Cell. 1995; 82:19-28.
Rooney P, Kumar S, Ponting J, Wang M. The role of hyaluronan in tumour neovascularization (review). Int J Cancer. 1995; 60:632-636.
Akima K, Ho H, Iwata Y, Matsuo K, Watari N, Yanagi M, Hagi H, Oshima K, Yagita A, Atomi Y, Tatekawa I. Evaluation of antitumor activities of hyaluronate binding antitumor drugs:
Synthesis, characterization and antitumor activity. J Drug Target. 1996; 4:1-8.
Coradini D, Pellizzaro C, Miglierini G, Daidone MG, Perbellini A. Hyaluronic acid as drug delivery for sodium butyrate: Improvement of the anti-proliferative activity on a breast-cancer cell line. Int J Cancer. 1999; 81:411-416.
Luo Y, Prestwich GD. Synthesis and selective cytotoxicity of a hyaluronic acid–antitumor bioconjugate. Bioconjug Chem. 199910:755–763.
Zalipsky S, Gilon C, Zilkha A. Attachment of drugs to polyethylene glycols. Eur Polym J. 1983; 19:1177-1183.
Jo Y-u, Lee CB, Bae SK, Na K. Acetylated hyaluronic acid-poly (L-lactic acid) conjugate nanoparticles for inhibition of doxorubicinol production from doxorubicin. Macromolecular Res. 2020;28(1):67- 73.
Kim SY, Lee YM. Taxol-loaded block copolymer nanospheres composed of methoxy poly (ethylene glycol) and poly (1-caprolactone) as novel anticancer drug carriers. Biomaterials. 2001; 22:1697-1704.
Shuai X, Ai H, Nasongkla N, Kim S, Gao J. Micellar carriers based on block copolymers of poly (1-caprolactone) and poly (ethylene glycol) for doxorubicin delivery. J Control Rel 2004;. 98:415-426.
Gref R, Couvreur P, Barratt G, Mysiakine E. Surfaceengineered nanoparticles for multiple ligand coupling. Biomaterials. 2003; 24:4529-4537.
Park EK, Lee SB, Lee YM. Preparation and characterization of methoxy poly(ethylene glycol)/poly (1-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folatemediated targeting of anticancer drugs. Biomaterials. 2005; 26:1053-1061.
Prajapati SK, Jain A, Jain A, Jain S. Biodegradable polymers and constructs: A novel approach in drug delivery. Eur Polym J. 2019; 120:109191.
Qindeel M, Ahmed N, Shah KU, Ullah N. New, environment friendly approach for synthesis of amphiphilic PCL–PEG–PCL triblock copolymer: an efficient carrier for fabrication of nanomicelles. J Polym Environ. 2020;28(4):1237-51.
Published
Abstract Display: 485 
PDF Downloads: 430 
